Company Overview

Charlotte's Web Holdings, Inc. is a U.S.-based consumer packaged goods company operating primarily in the hemp-derived wellness and botanical supplements industry. The company develops, manufactures, and markets products formulated from hemp extract, with a focus on cannabidiol (CBD) and other hemp-derived phytochemicals. Its offerings are positioned within the broader natural health, wellness, and nutraceutical markets, targeting consumers seeking plant-based supplements for general wellness, sleep, stress, and recovery.

The company’s core revenue is driven by branded consumer products sold through retail, e-commerce, and business-to-business channels. Charlotte’s Web is widely recognized for its early role in the commercialization of hemp-derived CBD products in the United States, benefiting from strong brand recognition tied to its origin story. Founded by the Stanley family, the company traces its roots to the development of a proprietary hemp strain used to support pediatric epilepsy, which became the foundation of its brand identity. Charlotte’s Web Holdings, Inc. completed its public listing in 2018 and has since evolved into a vertically integrated hemp wellness company.

Business Operations

Charlotte’s Web operates through a vertically integrated model encompassing hemp cultivation, product formulation, extraction, manufacturing, and distribution. Its primary operating segments include Branded Consumer Products, which represent the majority of revenue, and Bulk Hemp Extract and Ingredients, which supply other manufacturers and formulators. Products are sold under the flagship Charlotte’s Web™ brand and include CBD oils, gummies, capsules, topicals, and functional wellness products.

Operations are primarily domestic, with cultivation and manufacturing assets located in the United States. The company controls proprietary genetics, extraction technologies, and quality assurance processes, enabling traceability from seed to shelf. Charlotte’s Web also operates a direct-to-consumer e-commerce platform and maintains distribution relationships with national grocery, mass retail, natural products, and specialty wellness chains.

Strategic Position & Investments

The company’s strategic direction centers on brand-led growth, operational efficiency, and regulatory readiness within the evolving U.S. hemp and cannabinoid landscape. Charlotte’s Web has invested in research and development focused on full-spectrum hemp formulations, minor cannabinoids, and functional wellness applications, while also pursuing cost rationalization initiatives to improve margins.

Strategically, the company has expanded into adjacent botanical wellness categories beyond CBD to mitigate regulatory and market concentration risk. It has also invested in manufacturing optimization and supply chain control rather than pursuing large-scale acquisitions. Where applicable, investments have emphasized intellectual property, product innovation, and compliance capabilities aligned with anticipated federal regulatory frameworks.

Geographic Footprint

Charlotte’s Web is headquartered in the United States, with its principal executive offices in Colorado. Its primary cultivation, extraction, and manufacturing operations are also U.S.-based, supporting compliance with domestic hemp regulations and quality standards. The company’s products are distributed across all major U.S. regions through both online and brick-and-mortar retail channels.

Internationally, Charlotte’s Web has maintained a limited but strategic presence, primarily through export, licensing, or partnership arrangements rather than large-scale foreign operations. Its international activities have historically focused on select North American and European markets, with exposure influenced by local regulatory conditions governing hemp-derived products.

Leadership & Governance

Charlotte’s Web was founded by members of the Stanley family, who played a central role in establishing the company’s mission-driven brand and early market leadership. Governance is overseen by a board of directors with experience in consumer products, agriculture, and regulated industries. Management has emphasized disciplined execution, regulatory compliance, and brand credibility as core elements of its leadership philosophy.

Key executives include:

• Jacques Tortoroli – Chief Executive Officer
• Joel Stanley – Co-Founder and Chairman
• Jared Stanley – Co-Founder and President
• Tyler Van Sickle – Chief Financial Officer
• Deanie Elsner – President of Branded Products

Leadership has articulated a strategic vision focused on stabilizing financial performance, expanding brand relevance beyond CBD alone, and positioning the company for long-term participation in the regulated wellness and nutraceutical markets.